Viatris to acquire Pacira Biosciences for $1.65 billion
Viatris announced a plan to buy Pacira Biosciences for $1.65 billion, driving Pacira shares up while Viatris shares fell.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
6 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Viatris announced a plan to buy Pacira Biosciences for $1.65 billion, driving Pacira shares up while Viatris shares fell.
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling over 150 points on Thursday. The Dow traded down 0.39% to 50,978.59 while the NASDAQ declined 0.61% to 27,371.84. The S&P 500 also fell, dropping, 0.37% to 7,772.65. Leading and Lagging Sectors Energy shares jumped by 3% on Thursday. In
U.S. stocks were lower, with the Nasdaq Composite falling around 100 points on Thursday. Shares of Helen of Troy Limited (NASDAQ: HELE ) rose sharply after the company reported better-than-expected second-quarter adjusted EPS results and raised its FY27 GAAP EPS guidance. Adjusted earnings per share rose 33.9% to 79 ce
Lexicon Pharmaceuticals (NASDAQ: LXRX ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at Summary Lexico
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings
Viatris Inc receives analyst report, potentially impacting stock price